Valuation
- Market cap
- 1,000
- Revenue TTM
- $3,420,000
- Net income TTM
- $-32,670,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -955.26%
- Debt to equity
- -0.02
Trading
- Volume
- 100
- Avg volume
- 6,356
- Day's range
- $24.75 – $24.75
- Shares out
- 10,071,000
- Stochastic %K
- 68%
- Beta
- -1.77
- Analysts
- —
- Price target
- $3.00
Company profile
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software...
Show more
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
- Industry
- Capital Markets
- Sector
- Financial Services
- Phone
- 240 813 1260
- Website
- https://www.opgen.com
- Address
- 23219 Stringtown Road, Suite 300, Clarksburg, United States
Latest news
No headlines yet.
